Sugi Predict

Sugi Predict / Compounds / SCHEMBL723126

SCHEMBL723126

SCHEMBL723126

CC(C)c1cc(C=O)c(O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 2/20 0.53
▸ LMNA P02545 2/20 0.42
▸ TRPA1 O75762 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ ERN1 O75460 5/20 0.40
▸ TRIM24 O15164 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ HSP90AA1 P07900 3/20 0.39
▸ HSP90AB1 P08238 3/20 0.39
▸ PKM P14618 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29973971 1.00 TYR (0.53) TYRLMNATRPA1CHRM1SLC6A2
Hydrochloric Acid SCHEMBL28927068 0.98 TYR (0.52) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL15978282 0.92 TYR (0.53) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL3379260 0.84 LMNA (0.53) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL23094609 0.82 TYR (0.44) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL23829700 0.81 RORC (0.45) TYRERN1TRIM24TRIM33PKM
SCHEMBL18415735 0.80 LMNA (0.48) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL13649778 0.80 ALDH1A1 (0.53) TYRLMNAERN1TRIM24TRIM33
SCHEMBL14223114 0.80 MAPT (0.42) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL19923152 0.79 TYR (0.40) TYRERN1TRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397811-A Isoindoline derivatives that bind to ATP binding sites 奈奥芬莱有限公司 2022-11-25 — — CN claimed
CN-111164074-B Heat shock protein 90 inhibitors 台北医学大学 2024-02-02 — — CN disclosed
CN-115397811-A Isoindoline derivatives that bind to ATP binding sites 奈奥芬莱有限公司 2022-11-25 — — CN disclosed
US-11479528-B2 Heat shock protein 90 inhibitors TAIPEI MEDICAL UNIVERSITY (TW) 2022-10-25 — — US disclosed
US-11234987-B2 Isoxazole compounds as inhibitors of heat shock proteins CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2022-02-01 — — US disclosed
CN-113651806-A Preparation method of 4, 5-diaryl oxazole compound 福建医科大学 2021-11-16 — — CN disclosed
US-20210085700-A1 TARGETED THERAPEUTICS MADRIGAL PHARMACEUTICALS, INC. 2021-03-25 — — US disclosed
WO-2020205948-A1 HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF TARVEDA THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed
CN-111164074-A Heat shock protein 90 inhibitor 台北医学大学 2020-05-15 — — CN disclosed
US-20200039923-A1 HEAT SHOCK PROTEIN 90 INHIBITORS TAIPEI MEDICAL UNIVERSITY (TW) 2020-02-06 — — US disclosed
WO-2008044045-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 — — WO disclosed
WO-2008044029-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 — — WO disclosed
WO-2008044027-A2 PHARMACEUTICAL COMPOUNDS HAVING HSP90 INHIBITORY OR MODULATING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 — — WO disclosed
WO-2008044041-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 — — WO disclosed
WO-2008044054-A2 HYDROXY-SUBSTITUTED BENZOIC ACID AMIDE COMPOUNDS FOR USE IN THERAPY ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 — — WO disclosed
WO-2007139952-A2 METHOD FOR THE PREPARATION OF TRIAZOLE COMPOUNDS WITH HSP90 MODULATING ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2007-12-06 — — WO disclosed
US-20070276026-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2007-11-29 — — US disclosed
US-20070276026-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2007-11-29 — — US disclosed
US-20070259871-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2007-11-08 — — US disclosed
US-20070259871-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2007-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276026-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 HSP90AB1, HSP90AB2P, HSP90AA1 TYR 1029/4885LMNA 4532/4885TRPA1 1846/4885
US-20210085700-A1 TARGETED THERAPEUTICS CDC37, HSP90AB1, HSP90B1 TYR 1887/4885LMNA 3127/4885TRPA1 4306/4885
US-20070259871-A1 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 HSP90AB1, HSP90AB2P, HSP90AA1 TYR 1024/4885LMNA 4544/4885TRPA1 1852/4885
US-20200039923-A1 HEAT SHOCK PROTEIN 90 INHIBITORS HSP90AB1, HSP90AB2P, HSP90AA1 TYR 2077/4885LMNA 3431/4885TRPA1 3435/4885
US-11234987-B2 Isoxazole compounds as inhibitors of heat shock proteins HSP90AB1, HSP90AA1, HSP90AB2P TYR 1607/4885LMNA 3066/4885TRPA1 2704/4885
US-11479528-B2 Heat shock protein 90 inhibitors HSP90AB1, HSP90AB2P, HSP90AA1 TYR 2077/4885LMNA 3431/4885TRPA1 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.